Do analysts recommend BNBX or PMAX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Powell Max 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, BNBX or PMAX?

Powell Max has higher revenue and earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.09M 0.29 -$15.16M -$36.76 N/A Powell Max $6.12M 0.45 -$3.02M N/A N/A

Do analysts rate BNBX or TC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Token Cat 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, BNBX or TC?

Token Cat has lower revenue, but higher earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.09M 0.29 -$15.16M -$36.76 N/A Token Cat $850K 4.27 $320K N/A N/A

Do analysts rate BNBX or BAOS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Baosheng Media Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, BNBX or BAOS?

Baosheng Media Group has lower revenue, but higher earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.09M 0.29 -$15.16M -$36.76 N/A Baosheng Media Group $570K 73.85 -$12.02M N/A N/A

Do analysts prefer BNBX or FTFT?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Future FinTech Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate BNBX or SUGP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SU Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, BNBX or SUGP?

SU Group has higher revenue and earnings than Applied Dna Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Applied Dna Sciences $2.09M 0.29 -$15.16M -$36.76 N/A SU Group $24.72M 0.08 -$2.38M N/A N/A

Applied Dna Sciences (BNBX) Competitors

$0.08 0.00 (-3.10%)

As of 11:27 AM Eastern

Compare

BNBX vs. PMAX, TC, BAOS, FTFT, and SUGP

Should you buy Applied Dna Sciences stock or one of its competitors? MarketBeat compares Applied Dna Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Applied Dna Sciences include Powell Max (PMAX), Token Cat (TC), Baosheng Media Group (BAOS), Future FinTech Group (FTFT), and SU Group (SUGP). These companies are all part of the "business services" industry.

How does Applied Dna Sciences compare to Powell Max?

Applied Dna Sciences (NASDAQ:BNBX) and Powell Max (NASDAQ:PMAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

22.2% of Applied Dna Sciences shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Powell Max	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Applied Dna Sciences has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Powell Max has a beta of 2.22, suggesting that its stock price is 122% more volatile than the broader market.

Powell Max has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Powell Max's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Powell Max	N/A	N/A	N/A

In the previous week, Powell Max had 3 more articles in the media than Applied Dna Sciences. MarketBeat recorded 3 mentions for Powell Max and 0 mentions for Applied Dna Sciences. Powell Max's average media sentiment score of 0.96 beat Applied Dna Sciences' score of 0.00 indicating that Powell Max is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Powell Max	Positive

Powell Max has higher revenue and earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.29	-$15.16M	-$36.76	N/A
Powell Max	$6.12M	0.45	-$3.02M	N/A	N/A

Summary

Powell Max beats Applied Dna Sciences on 9 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to Token Cat?

Applied Dna Sciences (NASDAQ:BNBX) and Token Cat (NASDAQ:TC) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Token Cat has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Token Cat's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Token Cat	N/A	N/A	N/A

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 8.9% of Token Cat shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 0.5% of Token Cat shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Token Cat has lower revenue, but higher earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.29	-$15.16M	-$36.76	N/A
Token Cat	$850K	4.27	$320K	N/A	N/A

In the previous week, Token Cat had 3 more articles in the media than Applied Dna Sciences. MarketBeat recorded 3 mentions for Token Cat and 0 mentions for Applied Dna Sciences. Token Cat's average media sentiment score of 0.14 beat Applied Dna Sciences' score of 0.00 indicating that Token Cat is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Token Cat	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Token Cat	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Applied Dna Sciences has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, Token Cat has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Summary

Token Cat beats Applied Dna Sciences on 8 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to Baosheng Media Group?

Applied Dna Sciences (NASDAQ:BNBX) and Baosheng Media Group (NASDAQ:BAOS) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 6.3% of Baosheng Media Group shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 22.6% of Baosheng Media Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Baosheng Media Group has lower revenue, but higher earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.29	-$15.16M	-$36.76	N/A
Baosheng Media Group	$570K	73.85	-$12.02M	N/A	N/A

Applied Dna Sciences has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, Baosheng Media Group has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Baosheng Media Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Baosheng Media Group has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Baosheng Media Group's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Baosheng Media Group	N/A	N/A	N/A

In the previous week, Baosheng Media Group had 3 more articles in the media than Applied Dna Sciences. MarketBeat recorded 3 mentions for Baosheng Media Group and 0 mentions for Applied Dna Sciences. Baosheng Media Group's average media sentiment score of 0.50 beat Applied Dna Sciences' score of 0.00 indicating that Baosheng Media Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Baosheng Media Group	Neutral

Summary

Baosheng Media Group beats Applied Dna Sciences on 9 of the 11 factors compared between the two stocks.

How does Applied Dna Sciences compare to Future FinTech Group?

Applied Dna Sciences (NASDAQ:BNBX) and Future FinTech Group (NASDAQ:FTFT) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

22.2% of Applied Dna Sciences shares are owned by institutional investors. Comparatively, 0.2% of Future FinTech Group shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by company insiders. Comparatively, 1.5% of Future FinTech Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Applied Dna Sciences has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Future FinTech Group has a beta of 1.82, suggesting that its stock price is 82% more volatile than the broader market.

In the previous week, Future FinTech Group had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 1 mentions for Future FinTech Group and 0 mentions for Applied Dna Sciences. Future FinTech Group's average media sentiment score of 1.87 beat Applied Dna Sciences' score of 0.00 indicating that Future FinTech Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Future FinTech Group	Very Positive

Future FinTech Group has a net margin of -37.76% compared to Applied Dna Sciences' net margin of -1,647.25%. Future FinTech Group's return on equity of -13.08% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Future FinTech Group	-37.76%	-13.08%	-10.33%

Future FinTech Group has higher revenue and earnings than Applied Dna Sciences. Future FinTech Group is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.29	-$15.16M	-$36.76	N/A
Future FinTech Group	$3.83M	0.54	-$4.62M	-$12.68	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Future FinTech Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Future FinTech Group beats Applied Dna Sciences on 10 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to SU Group?

Applied Dna Sciences (NASDAQ:BNBX) and SU Group (NASDAQ:SUGP) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Applied Dna Sciences has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, SU Group has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SU Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

22.2% of Applied Dna Sciences shares are held by institutional investors. Comparatively, 68.1% of SU Group shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, SU Group had 2 more articles in the media than Applied Dna Sciences. MarketBeat recorded 2 mentions for SU Group and 0 mentions for Applied Dna Sciences. SU Group's average media sentiment score of 1.43 beat Applied Dna Sciences' score of 0.00 indicating that SU Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
SU Group	Positive

SU Group has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. SU Group's return on equity of 0.00% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
SU Group	N/A	N/A	N/A

SU Group has higher revenue and earnings than Applied Dna Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.29	-$15.16M	-$36.76	N/A
SU Group	$24.72M	0.08	-$2.38M	N/A	N/A

Summary

SU Group beats Applied Dna Sciences on 9 of the 11 factors compared between the two stocks.

Get Applied Dna Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNBX vs. The Competition

Export

Metric	Applied Dna Sciences	Services – Research, Development, Testing Labs Industry	Services Sector	NASDAQ Exchange
Market Cap	$607K	$7.74M	$16.54B	$12.13B
Dividend Yield	N/A	N/A	5.17%	9.80%
P/E Ratio	0.00	N/A	19.88	23.72
Price / Sales	0.29	1.65	36.90	90.51
Price / Cash	N/A	N/A	79.87	46.67
Price / Book	0.06	0.06	12.41	6.17
Net Income	-$15.16M	-$15.16M	-$15.57M	$331.26M
7 Day Performance	N/A	-5.76%	-1.60%	-0.06%
1 Month Performance	N/A	-12.22%	23.04%	-2.50%
1 Year Performance	N/A	N/A	138.84%	13.75%

Applied Dna Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNBX Applied Dna Sciences	0.2075 of 5 stars	$0.08 -3.1%	N/A	N/A	$607K	$2.09M	N/A	70
PMAX Powell Max	1.4465 of 5 stars	$1.82 +0.6%	N/A	-95.1%	$3.10M	$6.12M	N/A	N/A	Short Interest Decrease
TC Token Cat	0.368 of 5 stars	$2.01 +16.9%	N/A	-84.6%	$2.98M	$850K	N/A	620	Short Interest Increase
BAOS Baosheng Media Group	0.7912 of 5 stars	$1.89 +8.0%	N/A	-60.5%	$2.69M	$570K	N/A	130
FTFT Future FinTech Group	0.6086 of 5 stars	$1.49 +4.2%	N/A	-97.1%	$2.67M	$3.83M	N/A	70	Positive News High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNBX) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Applied Dna Sciences (BNBX) Competitors

BNBX vs. PMAX, TC, BAOS, FTFT, and SUGP

How does Applied Dna Sciences compare to Powell Max?

Summary

How does Applied Dna Sciences compare to Token Cat?

Summary

How does Applied Dna Sciences compare to Baosheng Media Group?

Summary

How does Applied Dna Sciences compare to Future FinTech Group?

Summary

How does Applied Dna Sciences compare to SU Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Applied Dna Sciences (BNBX) Competitors

BNBX vs. PMAX, TC, BAOS, FTFT, and SUGP

How does Applied Dna Sciences compare to Powell Max?

Do insiders & institutionals hold more shares of BNBX or PMAX?

Do analysts recommend BNBX or PMAX?

Which has more volatility & risk, BNBX or PMAX?

Is BNBX or PMAX more profitable?

Does the media refer more to BNBX or PMAX?

Which has higher valuation & earnings, BNBX or PMAX?

Summary

How does Applied Dna Sciences compare to Token Cat?

Is BNBX or TC more profitable?

Do insiders and institutionals have more ownership in BNBX or TC?

Which has better valuation and earnings, BNBX or TC?

Does the media prefer BNBX or TC?

Do analysts rate BNBX or TC?

Which has more volatility & risk, BNBX or TC?

Summary

How does Applied Dna Sciences compare to Baosheng Media Group?

Do institutionals & insiders have more ownership in BNBX or BAOS?

Which has higher valuation & earnings, BNBX or BAOS?

Which has more volatility and risk, BNBX or BAOS?

Do analysts rate BNBX or BAOS?

Is BNBX or BAOS more profitable?

Does the media prefer BNBX or BAOS?

Summary

How does Applied Dna Sciences compare to Future FinTech Group?

Do institutionals and insiders believe in BNBX or FTFT?

Which has more volatility & risk, BNBX or FTFT?

Does the media refer more to BNBX or FTFT?

Is BNBX or FTFT more profitable?

Which has higher earnings & valuation, BNBX or FTFT?

Do analysts prefer BNBX or FTFT?

Summary

How does Applied Dna Sciences compare to SU Group?

Which has more risk & volatility, BNBX or SUGP?

Do analysts rate BNBX or SUGP?

Do institutionals and insiders believe in BNBX or SUGP?

Does the media favor BNBX or SUGP?

Is BNBX or SUGP more profitable?

Which has higher earnings and valuation, BNBX or SUGP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools